Skip to content

non applicable

see below - GLUCIMAG-2

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2013-003526-92-FR
Enrollment
20
Registered
2013-12-10
Start date
2013-12-09
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Interventions

Product Name: 6-deoxy-6iodo D Glucose Product Code: 6-DIG Pharmaceutical Form:

Sponsors

INSERM
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: see below Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 20 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: see below

Design outcomes

Primary

MeasureTime frame
Main Objective: see below;Secondary Objective: see below;Primary end point(s): see below;Timepoint(s) of evaluation of this end point: NA

Secondary

MeasureTime frame
Secondary end point(s): NA;Timepoint(s) of evaluation of this end point: NA

Countries

France

Contacts

Public ContactSonia GUEGUEN

INSERM

rqrc.siege@inserm.fr33144236047

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Sep 19, 2026